Éter diisopropílico, mínimo 98 %, para síntesis, stab., 2,5 l, envase de vidrio

5-Methoxy-2-methylbenzoic acid, 98.0%, 1g

tert-Butyl 4-oxooctahydro-1H-indole-1-carboxylate, 98%, 100mg

7-Bromo-2-methylpyrido[2,3-b]pyrazine, 95.0%, 100mg

6-(o-tolyl)pyridazin-3(2H)-one, 95.0%, 250mg

Tert-butyl n-[1-(5-cyanopyridin-2-yl)piperidin-4-yl]carbamate, 95%, 100mg

(3-aminophenyl)(2-thienyl)methanol, 95.0%, 25g

2-(6-Aminopurin-9-yl)ethanol, 95.0%, 10g

3-acetyl-6-chloro-4-(4-fluorophenyl)quinolin-2(1H)-one, 95.0%, 500mg

1-Methyl-piperidine-3-carboxylic acid, 95.0%, 50g

2-Piperidinecarboxamide, N-[4-(4-methoxyphenyl)-2-thiazolyl]-1-[(4-methylphenyl)sulfonyl]-, (2R)-, 98%, 1g

5-Bromo-3-methyl-1,2,4-thiadiazole, 95.0%, 10g

Triheptylamine, 98%, 5g